Official announcements
Safety warnings
|
Blood & Tissue
|
17/04/2019
Only available in German
Safety warnings
|
Blood & Tissue
|
17/04/2019
Only available in German
Safety warnings
|
Blood & Tissue
|
17/04/2019
Only available in German
Safety warnings
|
Blood & Tissue
|
09/04/2019
Only available in German
Enforcement
|
06/04/2019
Great hopes of physicians as well as patients are attached to stem cell and other cell-based therapies. Major progress is expected particularly in the areas of difficult-to-treat and chronic diseases. In order to prevent hope to be transformed into a “trade with hope”, it is important for authorities to monitor this new therapeutic area.
Recall
|
Medicines
|
05/04/2019
The marketing authorisation holder informed its customers on April 4, 2019 that there is a risk that "Parkemed - Suspension zur oralen Anwendung" will likely contain levels of Lead (Pb) and Lithium (Li) which exceed the Permitted Daily Exposure (PDE) levels.
Recall
|
Veterinary Medicines
|
26/03/2019
The marketing authorisation holder and its distribution partner informed their customers on March 25, 2019 that particles had been detected in individual batches.
Recall
|
Medicines
|
11/03/2019
The marketing authorisation holder informed its customers on March 6, 2019 that the marketing of „Tetraspan 60 mg/ml Infusionslösung“ and „Venofundin 60 mg/ml Infusionslösung“ is ceased permanently for economic reasons.
Recall
|
Medicines
|
21/02/2019
The marketing authorisation holder informed its customers on February 19, 2019 that the marketing authorisation of „Vantobra 170 mg Lösung für einen Vernebler“ will be withdrawn.
messages in brief
|
21/02/2019
For more information on this topic, follow the link to the security features .